Dr. Miele Cosmed Group (DMG) Fair Value & Analysis
Consumer Defensive · PL · Market cap 206M PLN
Fair value as of: Jul 11, 2026
From 26 valuation models · updated 30 days ago
Fair value updated Jul 11, 2026, revised from 3.84 PLN to 4.29 PLN (+11.7%) since Jun 24, 2026. Share price −2.9% over the past month.
A solid business, screening 84% undervalued on our models.
What matters now
- The price is below even our cautious bear case (2.52 PLN). The market is more pessimistic than our downside scenario.
- Solid quality (56/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range (2.52 PLN to 5.74 PLN) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 11, 2026.
How to read this chart
60‑month range 1.81 PLN – 5.34 PLN · fair‑value band 2.52 PLN – 5.74 PLN · the 2.33 PLN price screens below the 4.29 PLN fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 11, 2026.
Analysis
Dr. Miele Cosmed Group (DMG) currently trades at 2.33 PLN, while our model-based Fair Value estimate is 4.29 PLN, implying the stock looks roughly 84.1% undervalued today. The Quality Score stands at 56/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Dr. Miele Cosmed Group generated revenue of 504M PLN at a net margin of 3.9%. Revenue grew 2.6% year over year. It earns a return on equity of 7.4%. Net debt stands at 37.5M PLN. Fundamentals as of Jul 11, 2026
Our scenario range runs from 2.52 PLN (bear case) to 5.74 PLN (bull case); at 2.33 PLN, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 40% below its 52-week high and 10% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -26% fair-value upside, at 84%, DMG screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: Multiples (3.90 PLN) versus Dividend Discount (0.5500 PLN). Highest evidence: Growth DCF (80).
Notify me when DMG reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 11, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 56 · Market factors (momentum, volatility) 36
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Dr. Miele Cosmed Group S.A. engages in the production and sale of chemical and cosmetic assortments in Poland and internationally.
Full company description
Dr. Miele Cosmed Group S.A. engages in the production and sale of chemical and cosmetic assortments in Poland and internationally. The company offers washing and care cosmetics, wet wipes, and laundry detergents for children; cleansing cosmetics, such as sanitizing gels and sprays, and liquid soaps; shower gels; and toilet cleaners, toilet blocks, and drain opener granules and gels; washing liquids and fabric softening concentrates; cleaning agents for kitchens and bathrooms; and hand sanitizing and surface disinfectants. The company markets its products primarily under the Bobini, Apart, Biophen, Mole, Sofin, Izo, and Izozid brands. The company was formerly known as Global Cosmed S.A. and changed its name to Dr. Miele Cosmed Group S.A. in March 2024. The company was founded in 1990 and is based in Radom, Poland.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Dr. Miele Cosmed Group reported revenue of 504M PLN in FY2025 versus 352M PLN in FY2021, a compound +9.4%/yr. Reported net income was 19.7M PLN in FY2025, compounding +14.2%/yr from FY2021.
Watch DMG: get an alert when its fair value changes →
Peer Group
Household & Personal Products · 244 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Household & Personal Products median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 11, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | $146.80 | $108.16 | -26% |
| Unilever PLC ULN | 1,080 MXN | 1,273 MXN | +18% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,144 | ₹1,000 | -53% |
| Essity AB ESSITYA | kr 279.00 | kr 250.02 | -10% |
| Godrej Consumer Products Limited GODREJCP | ₹1,088 | ₹367.64 | -66% |
| Marico Limited MARICO | ₹846.75 | ₹233.05 | -72% |
| APR Co 278470 | 375,000 KRW | 151,222 KRW | -60% |
| Dabur India Limited DABUR | ₹429.45 | ₹181.60 | -58% |
| Kimberly-Clark de México, S. A. B. de C. V., KIMBERA | 38.07 MXN | 50.09 MXN | +32% |
| PT Unilever Indonesia Tbk UNVR | 1,730 IDR | 1,934 IDR | +12% |
Compare Dr. Miele Cosmed Group with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Dr. Miele Cosmed Group (DMG) overvalued or undervalued?
What is the fair value of DMG?
What is the quality score of DMG?
What is the revenue of Dr. Miele Cosmed Group (DMG)?
What is the net profit margin of DMG?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Dr. Miele Cosmed Group and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.